NCT04418258 Capillary Endoscopy Aspiration Catheter
| NCT ID | NCT04418258 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cedars-Sinai Medical Center |
| Condition | Microbiota |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2020-05-20 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2020-05-20 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The small intestine is an understudied frontier of microbiome research. While aspiration during endoscopy is considered the gold standard to assess small bowel bacteria, the tools for sterile retrieval are primitive and poorly validated. Endoscopic aspiration is time-consuming and prone to contamination. Inspired by plants' ability to draw water by capillary action, a novel multi-capillary sterile system was designed which is a modified version of the conventional aspiration catheter. The purpose of this study is to examine the time and volume capabilities of this catheter in suctioning various liquids compared to conventional aspiration catheter, in two groups, each includes 23 patients that going under endoscopy at GI lab at Cedars Sinai Medical Center. The investigator will collect up to 2 ml fluid from Duodenum- in first group by using the conventional catheter and in second group by using the capillary catheter. The time collection and the volume of samples in 2 groups will be compared.
Eligibility Criteria
Inclusion Criteria: * Male or female subjects aged 18-85 undergoing esophagogastroduodenoscopy. Exclusion Criteria: * There are no exclusion criteria for this study as subjects will be undergoing the procedures for medical reasons and not for the purposes of this study.
Contact & Investigator
Ali Rezaie, MD
PRINCIPAL INVESTIGATOR
Cedars-Sinai Medical Center
Frequently Asked Questions
Who can join the NCT04418258 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Microbiota. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04418258 currently recruiting?
Yes, NCT04418258 is actively recruiting participants. Contact the research team at mastprogram@cshs.org for enrollment information.
Where is the NCT04418258 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT04418258 clinical trial?
NCT04418258 is sponsored by Cedars-Sinai Medical Center. The principal investigator is Ali Rezaie, MD at Cedars-Sinai Medical Center. The trial plans to enroll 46 participants.